Clincosm LogoSign in Get a demo

Locally Advanced Rectal Cancer

Showing 1 - 25 of 57
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Locally Advanced Rectal Cancer Trial in Beijing (capecitabine, tislelizumab, thymalfasin)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Beijing, China
  • +1 more
Sep 21, 2023

Locally Advanced Rectal Cancer, Older People Trial in Belgium (radiation, drug, procedure, combination product)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Older People
  • Short course radiotherapy
  • +3 more
  • Edegem, Antwerpen, Belgium
  • +12 more
Sep 18, 2023

Locally Advanced Rectal Cancer, Total Neoadjuvant Treatment, Anti-PD-1 Trial in Changchun (nCRT ? (CapeOX+Sintilimab)×6 ?

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • +2 more
  • nCRT → (CapeOX+Sintilimab)×6 → Surgery/W&W
  • Changchun, Ji Lin, China
    First Hospital of Jilin University
Aug 11, 2023

Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 5, 2023

Evaluation of Inflammatory Markers in LARC Patients

Completed
  • Locally Advanced Rectal Cancer
  • Inflammatory markers
  • (no location specified)
Jun 8, 2023

Locally Advanced Rectal Cancer, Locally Recurrent Rectal Cancer Trial in Southampton (Intraoperative Electron Radiotherapy

Recruiting
  • Locally Advanced Rectal Cancer
  • Locally Recurrent Rectal Cancer
  • Intraoperative Electron Radiotherapy (IOERT)
  • Extended Margin Surgery
  • Southampton, Hampshire, United Kingdom
    University Hospital Southampton NHS Foundation Trust
May 24, 2023

Locally Advanced Rectal Cancer Trial in Beijing (Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor), Long-course

Recruiting
  • Locally Advanced Rectal Cancer
  • Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor)
  • Long-course chemoradiation, without Tislelizumab (PD-1 inhibitor)
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Apr 25, 2023

Locally Advanced Rectal Cancer Trial (AK104 injection, TME surgery, Capecitabine)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • AK104 injection
  • +3 more
  • (no location specified)
Apr 4, 2023

Locally Advanced Rectal Cancer Trial in United States (structured treadmill walking)

Recruiting
  • Locally Advanced Rectal Cancer
  • structured treadmill walking
  • Basking Ridge, New Jersey
  • +6 more
Mar 30, 2023

Locally Advanced Rectal Cancer Trial in Japan (SCRT, CAPOX, CAPOXIRI)

Recruiting
  • Locally Advanced Rectal Cancer
  • SCRT
  • +2 more
  • Chiba, Japan
  • +21 more
Dec 9, 2022

Locally Advanced Rectal Cancer Trial in Miami (Intensity-modulated radiation therapy, 5-fluorouracil, Leucovorin)

Recruiting
  • Locally Advanced Rectal Cancer
  • Intensity-modulated radiation therapy
  • +5 more
  • Miami, Florida
    University of Miami
Oct 28, 2022

Locally Advanced Rectal Cancer Trial (PD-1 inhibitor, Capecitabine, Long-course radiation therapy)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • PD-1 inhibitor
  • +2 more
  • (no location specified)
Aug 16, 2022

Locally Advanced Rectal Cancer Trial in Shijiazhuang (Tislelizumab, Short-course radiotherapy, Capecitabine+Oxaliplatin)

Recruiting
  • Locally Advanced Rectal Cancer
  • Shijiazhuang, Hebei, China
    Fourth Hospital of Hebei Medical University
Aug 1, 2022

Locally Advanced Rectal Cancer Trial in Shanghai (SHR-1701;Capecitabine;Oxaliplatin)

Recruiting
  • Locally Advanced Rectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Zhongshan Hospital
Jul 26, 2022

Locally Advanced Rectal Cancer Trial in Spain, United States (Peposertib 50 mg, Peposertib 100 mg, Peposertib 150 mg)

Completed
Has Results
  • Locally Advanced Rectal Cancer
  • Peposertib 50 mg
  • +5 more
  • Aurora, Colorado
  • +13 more
Jun 9, 2022

Locally Advanced Rectal Cancer Trial (Radiation therapy, chemo and immune checkpoint inhibitor)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Radiation therapy, chemotherapy and immune checkpoint inhibitor
  • (no location specified)
Mar 28, 2022

Locally Advanced Rectal Cancer Trial in Pisa (drug, radiation, procedure)

Recruiting
  • Locally Advanced Rectal Cancer
  • Pisa, Italy
    U.O. Oncologia Medica 2 Universitaria - Azienda Ospedaliero-Univ
Mar 9, 2022

Inflammation After Laparoscopic Robot-assisted Surgery for

Recruiting
  • Locally Advanced Rectal Cancer
  • Abdominoperineal Resection
    • Oslo, Norway
      The Norwegian Radium Hospital Oslo University Hospital
    Nov 17, 2021

    Surgical Approaches in Pelvic Exenterative Surgery

    Recruiting
    • Pelvic Exenteration
    • +2 more
      • Dublin, Ireland
        St. Vincent's Hospital
      Oct 12, 2021

      Locally Advanced Rectal Cancer Trial in Hangzhou (Dendrobium Huoshanense Suppository)

      Recruiting
      • Locally Advanced Rectal Cancer
      • Dendrobium Huoshanense Suppository
      • Hangzhou, Zhejiang, China
        Ji Zhu
      Oct 1, 2021

      Locally Advanced Rectal Cancer Trial (GEN-001)

      Not yet recruiting
      • Locally Advanced Rectal Cancer
      • (no location specified)
      Oct 3, 2021

      PelvEx 4: Advanced Pelvic Malignancy and Role of

      Not yet recruiting
      • Multidisciplinary Communication
      • +4 more
      • No specific intervention; cases are retrospective and patients have already been treated.
      • Dublin, Ireland
        St. Vincent's Hospital
      Oct 12, 2021

      Rectal Cancer to Verify if Response After Chemo-radiotherapy Can

      Terminated
      • Locally Advanced Rectal Cancer
      • Neoadjuvant radiotherapy
      • +2 more
      • Lugano, Switzerland
      • +1 more
      Oct 5, 2021

      Locally Advanced Rectal Cancer Trial in Ljubljana (consolidation chemo, induction chemo)

      Recruiting
      • Locally Advanced Rectal Cancer
      • consolidation chemotherapy
      • induction chemotherapy
      • Ljubljana, Slovenia
        Institute of Oncology
      Sep 19, 2021

      Locally Advanced Rectal Cancer Trial in Guangzhou (Fruquintinib plus Tislelizumab)

      Not yet recruiting
      • Locally Advanced Rectal Cancer
      • Fruquintinib plus Tislelizumab
      • Guangzhou, Guangdong, China
        651 Dongfeng Road East
      Aug 3, 2021